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DNA replication and RNA transcription compete for
the same substrate during S phase. Cells have
evolved several mechanisms to minimize such con-
flicts. Here, we identify the mechanism by which the
transcription termination helicase Sen1 associates
with replisomes. We show that the N terminus of
Sen1 is both sufficient and necessary for replisome
association and that it binds to the replisome via the
components Ctf4 and Mrc1. We generated a separa-
tion of function mutant, sen1-3, which abolishes repli-
some binding without affecting transcription termina-
tion. We observe that the sen1-3 mutants show
increased genome instability and recombination
levels. Moreover, sen1-3 is synthetically defective
with mutations in genes involved in RNA metabolism
and the S phase checkpoint. RNH1 overexpression
suppresses defects in the former, but not the latter.
These findings illustrate how Sen1 plays a key func-
tion at replication forks during DNA replication to pro-
mote fork progression and chromosome stability.
INTRODUCTION
The maintenance of genome stability requires the complete and
faithful duplication of DNA in every cell cycle. Yet several obsta-
cles impede the progression of replication forks (RFs), and these
must be removed to avoid stalling and increased chromosome
instability. A significant barrier to RF progression is transcription.
First identified in bacteria, collisions between RFs and transcrip-
tion bubbles also represent a major obstacle for DNA synthesis
in eukaryotes, leading to defects in chromosome maintenance
and an increase in levels of recombination (Liu and Alberts,
1995; Helmrich et al., 2011, 2013; Prado and Aguilera, 2005;
Kim et al., 2010; Hamperl et al., 2017; Tran et al., 2017). In order
to complete the full duplication of the chromosomes, replisomes
must therefore overcome transcriptional barriers, removing both
the DNA-bound RNA polymerase subunits and any DNA:RNA
hybrids formed during transcription. These hybrids, usually
limited to eight base pairs, occur naturally during RNA transcrip-
tion and are typically removed when the RNA polymerase is
disengaged from the DNA (Aguilera and Garcı´a-Muse, 2012;
Westover et al., 2004).2094 Cell Reports 30, 2094–2105, February 18, 2020 ª 2020 The Aut
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can also form behind the site of RNA synthesis, through the
re-annealing of nascent RNA to the template DNA and the
displacement of the non-template DNA. These structures,
named R-loops, form preferentially at highly transcribed genes
with a high GC skew and can extend up to 1 kb in higher eukary-
otes (Aguilera and Garcı´a-Muse, 2012; Skourti-Stathaki et al.,
2014). Formation of R-loops is favored by head-on collisions be-
tween RFs and actively transcribing complexes (Hamperl et al.,
2017; Lang et al., 2017), and their non-physiological accumula-
tion, coupled to chromatin modification, is deleterious for
genome stability (Garcı´a-Pichardo et al., 2017). Several path-
ways minimize the formation and stability of R-loops. For
instance, the promotion of transcription processivity (Hazelbaker
et al., 2013), transcription termination (Kim et al., 2004; Luke
et al., 2008), timely processing, export or degradation of nascent
mRNA (Huertas and Aguilera, 2003; Pfeiffer et al., 2013), or pre-
venting torsional stress that arises during transcription (El Hage
et al., 2010, 2014) all minimize R-loops’ levels. Nevertheless,
once formed, R-loops must be removed. A key role in R-loop
removal is fulfilled by the RNase H enzymes that specifically
digest RNA molecules within DNA:RNA hybrids (Cerritelli and
Crouch, 2009). In addition, several helicases can unwind
DNA:RNA hybrids in vitro, including Sgs1 (Chang et al., 2017)
and Pif1 (Boule´ and Zakian, 2007). One such helicase, Sen1, is
believed to play an essential role in the removal of R-loops
from the DNA in yeast (Mischo et al., 2011).
Sen1 is an Upf1-like helicase that plays a key role in transcrip-
tion termination (Jankowsky, 2011; Steinmetz et al., 2006; Ursic
et al., 1997; Porrua and Libri, 2013). Sen1 binds to the free 50
ends of either RNA or DNA substrates and unwind both dou-
ble-stranded DNA (dsDNA) and DNA:RNA hybrids (Han et al.,
2017; Leonait _e et al., 2017; Martin-Tumasz and Brow, 2015; Por-
rua and Libri, 2013). In vitro analysis shows that Sen1 has high
activity but limited processivity on DNA:RNA hybrid substrates
(Han et al., 2017). Mechanistically, when Sen1 engages with
nascent RNA exiting from a stalled RNA polymerase II (RNAPII),
the helicase seemingly exerts a force on the polymerase to
‘‘push’’ it, either overcoming the stalling of RNAPII or disengag-
ing it from the template DNA (Porrua and Libri, 2013; Han et al.,
2017). In vivo data also suggest that Sen1 is capable of removing
RNAPII from the DNA it is bound to, thus terminating transcrip-
tion (Steinmetz et al., 2006; Schaughency et al., 2014; Hazel-
baker et al., 2013). In fact, a mutation in the catalytic domain of
Sen1 (sen1-1) confers defects in transcription termination at
non-permissive temperatures, leading to extensive readthroughhors.
commons.org/licenses/by/4.0/).
Figure 1. Sen1 Interacts with the Replisome during S Phase through Its N-Terminal Domain
(A)SEN1 or SEN1-TAP cells were arrested in G1, harvested immediately, or released for either 30min (S phase) or 60min (G2 phase). Cell extracts and IPmaterial
were analyzed by immunoblotting (IB).
(B) Schematic of Sen1 constructs used.
(C) TAP-tagged fragments of Sen1, IPed from cells in S phase, were analyzed by IB.
(D) TAP-tagged fragments of Sen1were analysed as above, except 43 cells were used for the IP of the fragments containing the last 330 C-terminal amino acids.of several transcription units (Steinmetz et al., 2006), accumula-
tion of R-loops, and increased recombination (Mischo et al.,
2011). Because of these defects, the viability of sen1-1 cells de-
pends on several repair factors (Mischo et al., 2011; Alzu et al.,
2012). Moreover, depletion of Sen1 leads to slow DNA replica-
tion and the accumulation of abnormal structures on 2D gels
(Alzu et al., 2012; Brambati et al., 2018).
Given its relatively low abundance and processivity (Mischo
et al., 2018; Han et al., 2017), Sen1 needs to be recruited at, or
close to, sites where it can enact its biological function. Sen1
is recruited to the termination sites of cryptic-unstable tran-
scripts (CUTs) and small nucleolar RNAs (snoRNAs) by binding
to Nab3 and Nrd1, which both dock onto nascent RNA (Arigo
et al., 2006; Porrua et al., 2012; Creamer et al., 2011). Nrd1
also interacts with Rpo21Rpb1 (the largest subunit of RNAPII)
early in the transcription cycle (Vasiljeva et al., 2008), thus re-
stricting Sen1-dependent termination to short transcription units
(Gudipati et al., 2008). Sen1 also promotes termination of some
genes downstream of the polyadenylation site, acting with Rat1
(Mischo et al., 2011; Rondo´n et al., 2009), possibly by directly
binding Rpo21 via its N-terminal domain (Chinchilla et al.,
2012). Finally, it is likely that Sen1 is recruited at other genomic
sites in a transcription-independent fashion. The human ortholog
of Sen1 (Senataxin) co-localizes with 53BP1 to sites of DNA
damage in a checkpoint-dependent manner (Y€uce and West,
2013). Moreover, in S. cerevisiae, Sen1 co-localizes with repli-
some components and sites of bromodeoxyuridine (BrdU) incor-poration (Alzu et al., 2012). However, the mechanism through
which Sen1 is recruited at RFs has yet to be described. The
significance of recruiting Sen1 to RFs is also poorly understood,
as it has been impossible thus far to determine whether the de-
fects in DNA replication upon inactivation of Sen1 are an indirect
consequence of deregulated transcription termination, of a fail-
ure in R-loop removal, or the direct result of an important function
of Sen1 at RFs. Here, we show that Sen1 binds the replisome
during S phase through its N-terminal domain, map its binding
site, generate a mutant that breaks this interaction, and explore
the consequences of the loss of the helicase from RFs on
chromosome stability.
RESULTS
Sen1 Interacts with the Replisome via Its N-Terminal
Domain
The replisome is a complex and dynamic machine that relies on
multiple interactions between its constituent proteins (Bell and
Labib, 2016; Burgers and Kunkel, 2017). As part of a mass spec-
trometry (MS) screen to identify factors transiently or weakly
associated to the core replisome, we observed that Sen1 co-pu-
rifies with the CMG helicase in S. cerevisiae (Figure S1A). To
verify the MS data, we immunoprecipitated (IPed) Sen1 from ex-
tracts of yeast cells synchronized in G1, S, and G2. We observed
that Sen1 interacted with replisome components only in S phase
(Figure 1A). Immunoprecipitation (IP) of the GINS componentCell Reports 30, 2094–2105, February 18, 2020 2095
(legend on next page)
2096 Cell Reports 30, 2094–2105, February 18, 2020
Sld5 corroborated this observation (Figure S1B). Sen1 interacts
with replisomes independently of either Nrd1 or Nab3 (Figures
S1C and S1D) and independently of ongoing transcription (Fig-
ures S1E and S1F), as previously observed (Alzu et al., 2012).
To further explore this interaction and its biological function,
we mapped the interaction sites both in the replisome and Sen1.
Sen1 contains an extended N-terminal domain and an essen-
tial and conserved helicase domain (Leonait _e et al., 2017). To
identify a region of Sen1 that is sufficient for binding replisomes,
we generated TAP-tagged constructs of Sen1, expressed under
an inducible GAL1 promoter (Figure 1B). All fragments contain-
ing the helicase domain folded correctly and rescued sen1-1
lethality at non-permissive temperatures, despite constructs
containing the last 330 amino acids of the protein being highly
labile (Figures S1G and S1H). We then assessed the ability of
the various fragments to interact with the replisome and
observed that the N-terminal domain (residues 2–931) of Sen1
was both sufficient and necessary for association with repli-
somes (Figures 1C and 1D). Similarly, Sen1 (2–931) co-precipi-
tated specifically with replisomes isolated from S phase cells
by IP of Mcm3 (a subunit of the CMG helicase) (Figures S1I
and S1J). Thus, Sen1 (2–931) contains an interaction site for re-
plisome components.
Sen1 Binding to the Replisome Depends on Ctf4 and
Mrc1
To identify specific proteins to which Sen1 binds within the
replisome, we compared the G1 and S phase interactome of
Sen1 (2–931) via MS analysis. As expected, Sen1 (2–931) IPed
with replisomes in S phase (Figure 2A). Interestingly, Ctf4 and
GINS co-purified with the bait in G1 as well. This was confirmed
by immunoblotting (Figures 2B and 2C). Because Ctf4 and GINS
interacts throughout the cell cycle (Gambus et al., 2009), we
next analyzed whether Sen1 binds preferentially to one of the
components. The interaction between Ctf4 and Sen1 in G1
was unaffected by inactivating GINS via the psf1-1 allele
(Figure 2B; Takayama et al., 2003), but GINS no longer IPed
with Sen1 (2–931) in G1 in the absence of Ctf4 (Figure 2C). These
data indicate that Sen1 (2–931) binds to Ctf4 in the absence of
other replisome components.
Interestingly, Sen1 (2–931) retained some affinity to the repli-
some in the absence of Ctf4 (Figure 2C, right panel), indepen-
dently of DNA (Figure S2A). This suggests that Sen1 interacts
with at least another subunit of the replisome. To screen forFigure 2. Sen1 Binds the Replisome Components Ctf4 and Mrc1
(A) MS analysis of the proteins co-purifying with Sen1 (2–931) was conducted in
(B) IB analysis of the proteins IPed with Sen1 (2–931) and an empty control in strai
for 1 h (G1), and then released into S phase for 20 min at 37C (S).
(C) Sen1 (2–931) binding of GINS in G1 depends on Ctf4. IB analysis of the proteins
arrested in G1 and released in S phase for 20 min at 30C. Ctf4 and TAP-Sen1 (
(D) IB analysis of the proteins interacting with TAP-Sen1 (2–931) in the presence
ure S2B. G1 samples were collected before galactose induction.
(E) Wild-type, mrc1D, or ctf4D cells expressing TAP-Sen1 (2–931) were arrested
(F) Wild-type, ctf4D,mrc1D, and ctf4Dmrc1-AID strains were arrested in G1, trea
released in S phase. IB analysis of cell extracts and IPs is shown.
(G) Quantification of the relative signal of Sen1-9MYC versus the TAP-Sld5 signa
(H) Experiments were conducted as in (F). Wild-type, ctf4D, and ctf4Dmrc1-AID st
a non-specific band.such factors, we analyzed whether any component of the repli-
some binds to Sen1 (2–931) in cells progressing into S phase
in the absence of origin firing. We used td-sld3-7 cells that
cannot initiate chromosome replication at 37C following inacti-
vation and degradation of td-Sld3-7 (Kamimura et al., 2001; Ka-
nemaki and Labib, 2006; Figure S2B). In control cells, Sen1 (2–
931) co-purified with all tested replisome components in S phase
(Figure 2D). In td-sld3-7 cells, Sen1 IPed predominantly with Ctf4
and GINS but also weakly with the replisome component Mrc1.
Strikingly, Sen1 (2–931)’s affinity for Mrc1 increased in a td-sld3-
7 ctf4D background. We confirmed this in cells arrested in G1 as
well (Figure 2E). These observations suggest that both Ctf4 and
Mrc1 are binding partners of Sen1 in the replisome. Deletion of
either replisome component leads to a decrease in replisome as-
sociation to Sen1, even following crosslinking to capture weak
interactions (Figures S2C and S2D). Because ctf4D mrc1D cells
are inviable (Gambus et al., 2009), we generated a ctf4D mrc1-
AID strain, with the auxin-degron fused to Mrc1 (Nishimura
et al., 2009) to allow rapid depletion of the protein. The associa-
tion of Sen1 with the replisome was greatly reduced, although
not entirely abolished, in cells with no Ctf4 and Mrc1 (Figures
2F–2H). These data indicate that, although other accessory bind-
ing partners might exist within the replisome, Sen1 mainly binds
via Ctf4 and Mrc1.
sen1-3 Fails to Bind the Replisome and Is Sensitive to
Increased Levels of DNA:RNA Hybrids
Deletion of the N-terminal domain of Sen1 causes pronounced
defects in cell growth (Figure S3A). Thus, to investigate the
role of Sen1 at RFs, we sought to generate a separation of
function allele that is specifically defective for binding to repli-
somes. By generating truncations of the N-terminal domain,
we identified that Sen1 (410–931) was the fragment with the
highest affinity for replisomes although Sen1 (622–931) was
the smallest construct still able to bind (Figures 3A–3C). By
comparison with yeast orthologs of Sen1 (Figure S3B), we
identified conserved residues within this region and targeted
them for mutagenesis, creating hemagglutinin (HA)-tagged al-
leles of SEN1 that were expressed under the strong ACT1 pro-
moter in sen1D cells. All the tested mutations supported cell
growth, but one allele, combining mutations W773A E774A
W777A (henceforth referred to as sen1-3) was uniquely defec-
tive for interaction with replisomes (Figures 3D and S3C).
Similar results were obtained when the sen1-3 mutation wasS and G1 phases.
ns carrying the PSF1 or psf1-1 allele. Cells were arrested in G1, shifted to 37C
IPed with Sen1 (2–931) and an empty control, with or withoutCTF4. Cells were
2–931) have similar sizes and run closely in gel electrophoresis.
or absence of origin firing and CTF4. Cells were treated as described in Fig-
in G1. IB analysis of cell extracts and IPs is shown.
ted for 1 h with 0.5 mM auxin indole-3-acetic acid (IAA) final concentration, and
l, normalized against the wild type.
rains, carrying an untagged or aSEN1-TAP allele, were used. Asterisk indicates
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Figure 3. Sen1-3 Does Not Interact with the Replisome
(A) Summary of the ability of N-terminal fragments of Sen1 to interact with the replisome.
(B) Cells carrying different GAL1-3HA-SEN1 fragments and a TAP-MCM3 allele were arrested in G1 and released into S phase. The samples were then used
for IPs.
(C) Sen1 fragments were analysed as in (B).
(D) Cells carrying ACT1-3HA-SEN1wild-type or mutated alleles at an ectopic locus were synchronously released into S phase. IB analysis of cell extracts and IPs
is shown.
(E) Cells carrying a SEN1, SEN1-TAP, or sen1-3-TAP allele were arrested in G1 and released into S phase. IB analysis of cell extracts and IPs is shown.
(F) Fluorescence-activated cell sorting (FACS) samples for the experiment in (E).introduced at the endogenous SEN1 locus (Figures 3E and
3F), even following crosslinking (Figure S3D). Importantly,
Sen1-3 retained wild-type affinity for RNAPII (Rpo21). Hence,
sen1-3 is an allele that abrogates the interaction between
Sen1 and replisomes.
Next, we assessed whether the sen1-3 mutation affects tran-
scription termination, similarly to sen1-1 cells (Mischo et al.,
2011). We assayed the efficiency of termination at two model
Nrd1-Nab3-Sen1 target genes, coding for a snoRNA (SNR13)
and a CUT (NEL025c) (Thiebaut et al., 2006; Ursic et al., 1997).
Because termination defects lead to longer RNAs that can be tar-
geted by the nonsense-mediated decay, strains lacking UPF1
were also tested (Culbertson and Leeds, 2003). Cells with the2098 Cell Reports 30, 2094–2105, February 18, 2020sen1-3 allele presented no defects in transcription termination,
unlike sen1-1 at 37C (Figures 4A and S3E). Defects in transcrip-
tion termination were also analyzed genome-wide by mapping
the distribution of RNAPII via the sequencing of nascent RNAs
using CRAC (crosslinking and analysis of cDNAs) (Granneman
et al., 2009; Candelli et al., 2018). Metagene analysis using a
set of validated CUTs (Table S1) shows very similar RNAPII pro-
files between SEN1 and sen1-3 cells, although a clear general
termination defect is observed upon depletion of Nrd1 (Figures
4B and S3F). These data indicate that sen1-3 is proficient in ter-
minating RNAPII transcription.
We then analyzed how the loss of Sen1 from replisomes af-
fects cells. SEN1 and sen1-3 cells displayed comparable cell
Figure 4. The sen1-3 Allele Is Proficient in RNAPII Termination but Is Essential in the Absence of RNase H Activity
(A) sen1-3 cells are proficient for transcription termination. qRT-PCR analysis of RNAs derived from the strains indicated is shown. The ratio of the readthrough
fraction (position RT) over the total amount of SNR13 RNA is shown (triplicate biological repeats). n.s., not significant.
(B) Metagene analysis of RNAPII density detected by CRAC on CUTs. Average read counts are plotted on regions aligned to both the transcription start site (TSS)
(left) and the transcript end site (TES) (right) of the CUTs (reads count in Table S1). The profiles of RNAPII density following Nrd1 depletion (nrd1-AID + auxin) are
included for comparison (dataset from Candelli et al., 2018). nrd1-AID strain behaves as a hypomorphic allele.
(C) Examples of the meiotic progeny of the indicated diploids strains are shown.
(D) Serial dilution spotting of the indicated strains is shown. rnh1D rnh201D is abbreviated as rnhDD.
(E) Serial dilution spotting of the indicated strains is shown. Cells (+RNH1) carry GAL-RNH1 inserted ectopically.
(legend continued on next page)
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growth kinetics and sensitivity to both hydroxyurea (HU) and
methyl methanesulfonate (MMS). One possibility might be that
Sen1 at RFs is redundant with the enzymatic activity of other fac-
tors, such as the RNase H1 and H2 enzymes. We crossed rnh1D
rnh201D cells with SEN1 or sen1-3 strains and analyzed their
meiotic progeny. Although single deletion of either RNH1 or
RNH201 combinedwith sen1-3 did not present any synthetic de-
fects, sen1-3 rnh1D rnh201D cells were inviable (Figure 4C),
similarly to rnh1D rnh201D sen1-1 mutants (Figure S3G). Over-
expression of sen1-3 under the strong ACT1 promoter sup-
presses the synthetic lethality of sen1-3 with rnh1D rnh201D,
suggesting that higher levels of Sen1 activity can compensate
for lack of the specific replisome-tethering mechanism. Yet
these cells display growth defects at 37C, with cells accumu-
lating in G2/M and triggering checkpoint activation (Figures
S3H–S3J). Moreover,ACT1-sen1-3 is unable to suppress the hy-
per-sensitivity of rnh1D rnh201D to HU and is synthetic defective
for MMS sensitivity (Figure 4D). Altogether, these findings sug-
gest that Sen1 at RF might either be redundant with RNases
H1 and H2 or become essential to deal with the DNA:RNA hy-
brids accumulating in the absence of RNase H.
To explore whether increased levels of DNA:RNA hybrids lead
to synthetic defects in sen1-3 cells, we generated hpr1D sen1-3
cells. Hpr1 is a component of the THO complex involved in the
processing and export of mRNA (Cha´vez et al., 2000). hpr1Dmu-
tants accumulate R-loops and show defects in transcription elon-
gation (Garcı´a-Benı´tez et al., 2017; Cha´vez and Aguilera, 1997;
Cha´vez et al., 2000). hpr1D sen1-3 double mutants showed
growth defects at higher temperatures and increased sensitivity
to replication stress (Figure 4E). To explore whether defects arise
duringDNA replication,we analyzed the kinetics of Rad52 foci for-
mation in cells released in S phase. The experiment was conduct-
ed at permissive temperatures (28C) as hpr1D cells failed to syn-
chronously bud at 35C and 37C. We observed that sen1-3
causes a small but statistically significant increase in recombina-
tion in lateS phase, although hpr1D sen1-3cells showed synthetic
defects and an increase in recombination (Figures 4F and S4A–
S4D). Interestingly, the increased rates of recombination and
growth defects in hpr1D sen1-3 cells were suppressed by overex-
pression of RNH1 (Figures 4E and 4F), thus suggesting that
DNA:RNA hybrids are toxic in these mutants.
To directly test the levels of DNA:RNA hybrids, we visualized
them in chromosome spreads (Wahba et al., 2011). As previously
observed, both rnh1D rnh201D and hpr1Dmutants showed high
levels of DNA:RNA hybrids (Figures 4G and S4E; Chan et al.,
2014). Surprisingly, we did not observe any increase in the levels
of DNA:RNA hybrids in hpr1D sen1-3 cells. Similar results were
observed by slot-blot analysis (Figure S4F). Given that pheno-
typic suppression by RNase H overexpression is accepted as
a marker for R-loops, these results suggest that the suppression
of hpr1D sen1-3 by overexpression of RNH1 might occur by
removing short or labile DNA:RNA hybrids, not readily detectable
by the S9.6 antibody used in our analysis.(F) The indicated strains, carrying a RAD52-GFP allele with or without theGAL-RN
at the indicated time points, fixed, and analyzed for the presence of Rad52 foci (
(G) The indicated strains were grown to exponential phase at 28C; DNA:RNA hyb
biological repeats). Samples were treated in parallel with RNase H.
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Progression and Genome Stability in the Absence of
MRC1
Because both sen1-1 and sen1-3 are synthetically lethal in the
absence of RNH1 and RNH201, we wanted to explore whether
other pathways, essential for maintaining cell viability in sen1-1
(Alzu et al., 2012; Mischo et al., 2011), are also important in
sen1-3. Only a subset of deletion mutants described to nega-
tively affect viability in sen1-1 cells showed robust defects in
cell viability in sen1-3 cells (summarized in Figure 5A). Namely,
we observed temperature sensitivity and increased sensitivity
to DNA-damaging agents when sen1-3 was crossed with either
mrc1D, ctf18D, or rad53D sml1D (Figure 5B).
Mrc1, Ctf18, and Rad53 are key components of the S phase
checkpoint, and all three mutants confer temperature sensitivity
in sen1-3 cells. To further explore the defects of mrc1D sen1-3
mutants, we analyzed the DNA replication dynamics of cells ar-
rested in G1 and then released in S phase at 37C. The mrc1D
sen1-3 cells show a delay during DNA replication and accumula-
tion of cells arrested in G2/M (Figure 5C). Correspondingly, we
observed an increase in Rad52-GFP foci accumulating during
the later stages of DNA replication, both in the mrc1D sen1-3
and ctf18D sen1-3 cells released in S phase at 37C (Figures
5D and 5E). In addition, mrc1D sen1-3 and ctf18D sen1-3 cells
showed an increase in cells carrying multiple foci of Rad52 (Fig-
ure S5A). Similar to what is seen in Figure 4F, we also observed a
small but statistically significant increase in Rad52 foci in sen1-3
mutants compared to wild-type. To determine whether
DNA:RNA hybrids contribute to the phenotypes observed in
sen1-3 mrc1D, we repeated the experiments following the over-
expression of RNH1. This failed to suppress the growth defects
and the increase in recombination during S phase (Figures 5F,
5G, and S5B). Similar results were obtained when overexpress-
ing the human ortholog of RNH1 (Figures S5C and S5D; Wahba
et al., 2011; Bonnet et al., 2017).
To analyze whether the increased recombination observed
during replication in sen1-3, mrc1D sen1-3, and hpr1D sen1-3
compared to SEN1 leads to an increase in genomic instability,
wemeasured the rate of direct-repeat recombination using plas-
mids carrying partially overlapping fragments of the LEU2 gene
separated by 39 or 3,900 nt (plasmids pL and pLYDNS, respec-
tively) (Mischo et al., 2011; Gonza´lez-Aguilera et al., 2008). We
observed, as previously described, that recombination
increased with the length of the transcript. Moreover, although
mrc1D sen1-3 showed a modest increase in recombination
compared to mrc1D for both plasmids, hpr1D sen1-3 showed
greater increases in the rate of recombination (Figure 5H).
Furthermore, we tested for defects in mini-chromosome mainte-
nance by transforming a single-copy plasmid carrying an ADE2
gene and scoring for the rate of plasmid loss in the absence of
selective pressure by measuring the rate of white colonies (car-
rying the plasmid) and red (without the plasmid). Cells carrying
the sen1-3 allele showed higher levels of plasmid loss,H1 construct, were grown as shown in Figures S4A–S4D. Samples were taken
triplicate biological repeats). n.s., not significant; **p < 0.05; ***p < 0.01.
rids were analyzed by immunofluorescence of chromosome spreads (triplicate
(legend on next page)
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exacerbated in the absence ofMRC1 and HPR1 (Figures 5I and
S5E). Strikingly, sen1-3 hpr1D completely failed to retain the
plasmid. The addition of a second origin of replication did not
rescue the chromosome maintenance defects, and overexpres-
sion of RNH1 only partially suppressed the defects in hpr1D
sen1-3 cells (Figure S5F).
DISCUSSION
Here, we have shown that Sen1 is a bona fide partner of the yeast
replisome. The N-terminal domain mediates binding to repli-
somes, mainly via Ctf4 and Mrc1. Additional binding partners
of Sen1 are likely because Sen1 shows some residual interaction
with replisomes in the absence of Ctf4 and Mrc1. It is not yet
clear whether multiple Sen1 molecules are recruited to RFs by
independently binding separate subunits of the replisome with
different affinities or whether multiple replisome components
coordinately bind a single Sen1 to increase its strength of inter-
action. IPs of the N-terminal domain of Sen1 suggest a compe-
tition betweenMrc1 and Ctf4 for Sen1 asMrc1 binding increases
in ctf4D cells (Figures 2D and 2E). This supports the multiple in-
dependent binding hypothesis. However, deletion of eitherCTF4
or MRC1 decreases overall binding of Sen1 to the replisome
(Figures 2F, 2H, S2C, and S2D), compatible with a cooperative
recruitment of Sen1. Interestingly, the mutation of three amino
acids in sen1-3 abolishes binding to both Ctf4 and Mrc1. Thus,
the mutated residues either correspond to the direct interaction
site for both Ctf4 and Mrc1 or they cause a change in conforma-
tion of a larger section of Sen1, thus affecting two distinct bind-
ing surfaces for Ctf4 andMrc1. Both hypotheses are compelling,
and further work is needed to determine which is correct.
The sen1-3 allele is a separation of functionmutant that breaks
the interaction with the replisomewithout affecting the binding to
RNAPII or transcription termination (Figures 3E, 4A, and 4B).
However, we cannot exclude that sen1-3 might affect other
Sen1 interactions beyond the replisome. In addition, minimal
levels of interaction with replisomes might be retained in sen1-
3 cells, thus weakening the severity of the phenotype observed.
Nevertheless, this allele provides us with a tool to dissect the
function of the helicase at RFs without affecting its catalytic ac-
tivity and the bulk of its transcription functions.Figure 5. sen1-3 Presents Synthetic Defects withmrc1D, ctf18D, and r
Loss
(A) Summary of the genetic interactions tested with the sen1-3 allele. Some doub
and DNA damage sensitivity although others did not (green line).
(B) Examples of the defects observed with sen1-3. Serial dilution spotting of the
rad53D.
(C) The indicated strains were arrested in G1, shifted to 37C for 1 h, and released
length of DNA replication; green arrow, beginning of the end of mitosis.
(D) Cells, carrying aRAD52-GFP allele, were treated as in (C). Samples were taken
(triplicate biological repeats). **p < 0.05; ***p < 0.01.
(E) Examples of the microscopy data of the experiment in (D). Scale bars represe
(F) Serial dilution spotting of the indicated strains is shown. Cells (+RNH1) carry
(G) RNH1 overexpression does not suppress the increase in recombination inmrc
YPGAL medium (triplicate biological repeats). **p < 0.05; ***p < 0.01.
(H) The sen1-3 allele causes an increase in recombination. The cells were transfo
carrying a recombinant plasmid (LEU2) over the total number of cells carrying a
(I) Cells were transformed with plasmids carrying an ADE2 marker and 1 or 2 orig
shown (a measure of genome stability; ***p < 0.5 107).
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Sen1 depletion) that Sen1’s presence at RFs is required to
quickly remove the R-loops accumulating and interfering with
RF progression (Alzu et al., 2012; Brambati et al., 2018; Mischo
et al., 2011). In our experimental setting, however, loss of Sen1
from RFs did not show increases in DNA:RNA hybrids or dra-
matic defects in RF progression (Figures 4G and 5C). In fact,
the loss of Sen1 from the replisome only leads to modest defects
(small increases in post-replicative recombination and instability
of mini-chromosomes; Figures 4F, 5D, and 5I). This suggests
that when Sen1 is proficient in transcription termination, there
might be enough redundancy at the RFs to deal with DNA:RNA
hybrids. However, we observe lethality or severe growth defects
when the sen1-3 allele is present in genetic backgrounds with
high endogenous levels of R-loops, such as rnh1D rnh201D
and hpr1D. This supports the idea of an important role for
Sen1 in dealing with DNA:RNA hybrids at RFs. Surprisingly, we
do not observe an increase in DNA:RNA hybrids levels in sen1-
3 and in hpr1D sen1-3 cells (Figures 4G, S4E, and S4F). More-
over, although increased levels of R-loops have been described
for top1D (El Hage et al., 2010), pif1D (Boule´ and Zakian, 2007;
Tran et al., 2017), sgs1D (Chang et al., 2017), or mlp1D (Gar-
cı´a-Benı´tez et al., 2017), these deletions do not show defects
in cell viability or DNA damage sensitivity in combination with
sen1-3 (Figure 5A). This suggests that not all increases in R-
loops might be necessarily toxic in sen1-3 cells. One possibility
is that different mutations might lead to dissimilar levels or
distinct biochemical features of the R-loops. Moreover, different
genetic backgrounds might lead to the accumulation of
DNA:RNA hybrids at different sites of the genome (as recently
observed; Costantino and Koshland, 2018). Therefore, Sen1 as-
sociation with the replisome might become critical for the timely
resolution of some DNA:RNA hybrids in specific circumstances.
The recruitment of Sen1 at RFs also appears to promote DNA
replication independently of R-loops. In fact, in sen1-3 cells,
overexpression of RNH1 fails to suppress the higher levels of
recombination observed in sen1-3 (Figures 4F and 5D). Given
the prominent role of Sen1 in transcription termination described
in the literature, it is tempting to speculate that Sen1 might re-
move transcribing or stalled RNA polymerases at RFs (Han
et al., 2017; Porrua and Libri, 2013). Alternatively, Sen1 mightad53D, Leading to Increased Recombination and Mini-chromosome
le mutants (orange line) showed marked differences in temperature sensitivity
indicated strains is shown. The double mutant rad53D sml1D is indicated as
in S phase at 37C. FACS samples were taken at the indicated times. Red bar,
at the indicated time points, fixed, and analyzed for the presence of Rad52 foci
nt 5 mm.
an ectopic GAL1-RNH1 construct.
1D sen1-3 cells. Cell cultures were treated as in (C), except they were grown in
rmed with the plasmids pL or pLYDNS. The ratio of the number of the colonies
plasmid (URA3) is shown.
ins. Percentage of white colonies over the total number of colonies scored is
be required to remove other barriers to fork progression, or
RNH1 overexpression might not be sufficient to remove
DNA:RNA hybrids present at RF with kinetics similar to Sen1,
thus leading to increased fork stalling. In either case, we observe
that cells rely on the functions of Mrc1 to promote fork progres-
sion and minimize DNA recombination in a sen1-3 background
(Figures 5B–5G). Interestingly, we observe that three key media-
tors and effectors of the S phase checkpoint (MRC1,CTF18, and
RAD53) genetically interact with sen1-3. We did not observe any
synthetic defects between sen1-3 and either mec1D sml1D,
tel1D, ormec1D sml1D tel1D (not shown). This raises the possi-
bility that Mrc1, Ctf18, and Rad53 might be involved in the
response to defects arising in sen1-3 cells independently of
Mec1 and Tel1. Alternatively, the synthetic defects observed
are the consequence of other deficiencies in these cells, inde-
pendent of the S phase checkpoint response. For example,
Mrc1 has a key role in RF progression (Yeeles et al., 2017; Hodg-
son et al., 2007; Duch et al., 2018).
Given that eukaryotic orthologs of Sen1 contain an extended
non-catalytic N-terminal sequence (the function of which is still
largely unknown), it will be interesting to investigate further
whether Senataxin or any of its paralogs (Aquarius, IGHMBP2,
RENT1, and ZNFx1) associate with replisomes in higher
eukaryotes.
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Chemicals, Peptides, and Recombinant Proteins
a-factor Pepceuticals N/A
AcTEV protease Thermo-Fischer 12575015
Calmodulin Sigma A6112
Complete protease inhibitor cocktail Roche 11 836 153 001
Dithiothreitol Sigma D0632
Dynabeads Invitrogen 14302D
Ethidium bromide Sigma E1510
Hydroxyurea Sigma H8627
Methyl methanesulfonate Sigma 129925
Propidium iodide Sigma P4864
Protease Inhibitor Cocktail Sigma P8215
Sodium fluoride Thermo-Fischer S299500
Zymolyase Zymo research #E1005
RNase H Invitrogen #18021071
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Sodium glycerophosphate Johnson Matthey 170096
Universal Nuclease Pierce 88700
Critical Commercial Assays
Amersham ECL Western Blotting Detection Reagent GE Healthcare RPN2108
LightCycler FastStart DNA Master SYBR Green I Roche 03003230001
MLV-Reverse Transcriptase Thermofischer 28025013
QuikChange Lightning Site-Directed Mutagenesis Kit QIAGEN #210519
Experimental Models: Organisms/Strains
S. cerevisiae (from W303) CS1MATa Rothstein’s lab N/A
S. cerevisiae (from W303) CS74MATa pep4D::ADE2 Lab strain N/A
S. cerevisiae (from W303) CS1125MATa TAP-SLD5 (kanMX) SEN1-
9MYC (hphNT) pep4D::URA3 ADE2
This study N/A
S. cerevisiae (from W303) CS1126MATa SEN1-9MYC (hphNT)
pep4D::URA3 ADE2
This study N/A
S. cerevisiae (from W303) CS1187MATa TAP-SLD5 (kanMX) SEN1-
9MYC (hphNT) pep4D::URA3 ADE2 ctf4D::kanMX
This study N/A
S. cerevisiae (from W303) CS1353MATa SEN1-TAP (kanMX)
pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1416MATa TAP-MCM3 (kanMX) SEN1-
9MYC (hphNT) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1711MATa TAP-MCM3 (kanMX)
GAL1-3HA-ø (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1714MATa TAP-MCM3 (kanMX)
leu2-3,112::GAL1-3HA-SEN1 (2-931) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (fromW303) CS1534MATa TAP-SLD5 (kanMX) SEN1-9MYC
(hphNT) pep4D::URA3 ADE2 mrc1D::hphNT
This study N/A
S. cerevisiae (fromW303) CS1852MATa leu2-3,112::GAL1-TAP-ø (LEU2)
pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1933MATa leu2-3,112::GAL1-TAP-SEN1
(1095-2231) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1941MATa leu2-3,112::GAL1-TAP-SEN1
(2-2231) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1942MATa leu2-3,112::GAL1-TAP-SEN1
(2-1901) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1943MATa leu2-3,112::GAL1-TAP-SEN1
(931-2231) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1956MATa leu2-3,112::GAL1-TAP-SEN1
(2-1103) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS1957MATa leu2-3,112::GAL1-TAP-SEN1
(2-931) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS2030MATa TAP-MCM3 (kanMX) leu2-
3,112::GAL1-3HA-SEN1 (2-622) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS2032MATa TAP-MCM3 (kanMX) leu2-
3,112::GAL1-3HA-SEN1 (410-931) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS2056MATa td-MYC-sen1-1 (klTRP1) GAL1-
UBR1 (HISMX) leu2-3,112::GAL1-TAP-ø (LEU2)
This study N/A
S. cerevisiae (from W303) CS2058MATa td-MYC-sen1-1 (klTRP1) GAL1-
UBR1 (HISMX) leu2-3,112::GAL1-TAP-SEN1 (2-931) (LEU2)
This study N/A
S. cerevisiae (from W303) CS2061MATa td-MYC-sen1-1 (klTRP1) GAL1-
UBR1 (HISMX) leu2-3,112::GAL1-TAP-SEN1 (2-1901) (LEU2)
This study N/A
S. cerevisiae (from W303) CS2062MATa td-MYC-sen1-1 (klTRP1) GAL1-
UBR1 (HISMX) leu2-3,112::GAL1-TAP-SEN1 (1095-2231) (LEU2)
This study N/A
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S. cerevisiae (from W303) CS2148MATa TAP-MCM3 (kanMX) leu2-
3,112::GAL1-3HA-SEN1 (501-931) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS2150MATa TAP-MCM3 (kanMX) leu2-
3,112::GAL1-3HA-SEN1 (622-931) (LEU2) pep4D::ADE2
This study N/A
S. cerevisiae (from W303) CS2184MATa td-MYC-sen1-1 (klTRP1) GAL1-
UBR1 (HISMX) leu2-3,112::GAL1-TAP-SEN1 (2-1103) (LEU2)
This study N/A
S. cerevisiae (from W303) CS2188MATa td-MYC-sen1-1 (klTRP1) GAL1-
UBR1 (HISMX) leu2-3,112::GAL1-TAP-SEN1 (2-2231) (LEU2)
This study N/A
S. cerevisiae (from W303) CS2451MATa td-MYC-sen1-1 (klTRP1) GAL1-
UBR1 (HISMX) leu2-3,112::GAL1-TAP-SEN1 (931-2231) (LEU2)
This study N/A
S. cerevisiae (from W303) CS2458MATa/MATa SEN1/SEN1 (931-2231)
(HISMX)
This study N/A
S. cerevisiae (from W303) CS2582MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (931-2231) (LEU2)
This study N/A
S. cerevisiae (from W303) CS2584MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) (LEU2)
This study N/A
S. cerevisiae (from W303) CS2603MATa leu2-3,112::GAL1-TAP-SEN1
(2-931) (LEU2) pep4D::ADE2 ctf4D::kanMX
This study N/A
S. cerevisiae (from W303) CS2607MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) W773A E774A W777A (LEU2)
This study N/A
S. cerevisiae (from W303) CS2609MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) D850A E851G V852A L853G
L854A (LEU2)
This study N/A
S. cerevisiae (from W303) CS2611MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) V858A R859A I862A (LEU2)
This study N/A
S. cerevisiae (from W303) CS2615MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) D876G D877G V880G (LEU2)
This study N/A
S. cerevisiae (from W303) CS2617MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) V746G D747G P748G I749G (LEU2)
This study N/A
S. cerevisiae (from W303) CS2623MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) L656A S657A K658A I659A L660
(LEU2)
This study N/A
S. cerevisiae (from W303) CS2636MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) L656A S657A K658A I659A L660A
(LEU2) NRD1- 9MYC (HIS3MX) pep4D:: ADE2 TAP-MCM3 (kanMX)
This study N/A
S. cerevisiae (from W303) CS2638MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2- 2231)W773A E774A W777A (LEU2) NRD1-
9MYC (HIS3MX) pep4D:: ADE2 TAP-MCM3 (kanMX)
This study N/A
S. cerevisiae (from W303) CS2640MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2- 2231) D850A E851G V852A L853G L854A
(LEU2) NRD1- 9MYC (HIS3MX) pep4D:: ADE2 TAP-MCM3 (kanMX)
This study N/A
S. cerevisiae (from W303) CS2642MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2- 2231) V746G D747G P748G I749G (LEU2)
NRD1-9MYC (HIS3MX) pep4D:: ADE2 TAP-MCM3 (kanMX)
This study N/A
S. cerevisiae (from W303) CS2669MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) (LEU2) NRD1-9MYC (HIS3MX) pep4D::
ADE2 TAP-MCM3 (kanMX)
This study N/A
S. cerevisiae (from W303) CS2670MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2- 2231) (LEU2) NRD1-9MYC (HIS3MX)
pep4D:: ADE2
This study N/A
S. cerevisiae (from W303) CS2716MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) D876G D877G V880G (LEU2)
This study N/A
S. cerevisiae (from W303) CS2718MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) T782G I783G Y784G (LEU2)
This study N/A
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S. cerevisiae (fromW303) CS2734MATa rnh1D:: hphNT rnh201D::HISMX Lab strain N/A
S. cerevisiae (fromW303) CS2735MATa rnh1D:: hphNT rnh201D::HISMX Lab strain N/A
S. cerevisiae (from W303) CS2791MATa td-sld3-7 (kanMX) GAL1-UBR1
(HIS3MX) leu2-3,112::GAL1-TAP-SEN1 (2-931) (LEU2+) pep4D:: ADE2
This study N/A
S. cerevisiae (from W303) CS2808MATa SEN1-TAP (kanMX) This study N/A
S. cerevisiae (from W303) CS2810MATa sen1-3-TAP (kanMX) This study N/A
S. cerevisiae (from W303) CS2853MATa SEN1-TAP (kanMX) pep4D::
ADE2
This study N/A
S. cerevisiae (from W303) CS2854MATa sen1-3-TAP (kanMX) pep4D::
ADE2
This study N/A
S. cerevisiae (from W303) CS2859MATa SEN1-TAP (kanMX) pep4D::
URA3 mrc1D::hphNT
This study N/A
C S. cerevisiae (from W303) S2861MATa sen1-3-TAP (kanMX) pep4D::
URA3 mrc1D::hphNT
This study N/A
S. cerevisiae (from W303) CS2903MATa td-sld3-7 (kanMX) GAL1-UBR1
(HIS3MX) leu2-3,112::GAL1-TAP-SEN1 (2-931) (LEU2) pep4D:: ADE2
ctf4D:: kanMX
This study N/A
S. cerevisiae (from W303) CS2938MATa SEN1-TAP (kanMX)
hpr1D::kanMX
This study N/A
S. cerevisiae (from W303) CS2941MATa sen1-3-TAP (kanMX)
hpr1D::kanMX
This study N/A
S. cerevisiae (from W303) CS2945MATa SEN1-TAP (kanMX)
sml1D::HISMX rad53D::ADE2
This study N/A
S. cerevisiae (from W303) CS2947MATa sen1-3-TAP (kanMX)
sml1D::HISMX rad53D::ADE2
This study N/A
S. cerevisiae (from W303) CS2955MATa SEN1-TAP (kanMX)
ctf18D::klTRP1
This study N/A
S. cerevisiae (from W303) CS2957MATa sen1-3-TAP (kanMX)
ctf18D::klTRP1
This study N/A
S. cerevisiae (from W303) CS3167MATa leu2-3,112::GAL1-TAP-SEN1
(2-931) (LEU2) pep4D::ADE2 psf1-1 (ts)
This study N/A
S. cerevisiae (from W303) CS3186MATa leu2-3,112::GAL1-TAP-SEN1
(2-931) (LEU2) pep4D::ADE2 mrc1D::hphNT
This study N/A
S. cerevisiae (fromW303) CS3321MATa leu2-3,112::GAL1-RNH1 (2-348)
(LEU2) SEN1-TAP (kanMX) mrc1D::hphNT
This study N/A
S. cerevisiae (fromW303) CS3322MATa leu2-3,112::GAL1-RNH1 (2-348)
(LEU2) sen1-3-TAP (kanMX) mrc1D::hphNT
This study N/A
S. cerevisiae (from W303) CS3499MATa SEN1-TAP (kanMX)
pep4D::ADE2 ctf4D::kanMX mrc1-3IAA (HISMX) ADH1-OsTIR1
(klTRP1,URA3)
This study N/A
S. cerevisiae (from W303) CS3545MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-sen1-3 (2-2231) (LEU2) rnh1D:: hphNT
rnh201D::HISMX
This study N/A
S. cerevisiae (from W303) CS3547MATa sen1D::URA3-CP leu2-
3,112::ACT1-3HA-SEN1 (2-2231) (LEU2) rnh1D:: hphNT
rnh201D::HISMX
This study N/A
S. cerevisiae (from W303) CS3562MATa SEN1-TAP (kanMX)
pep4D::ADE2 ctf4D::kanMX
This study N/A
S. cerevisiae (from W303) CS3662MATa SEN1-TAP (kanMX)
mrc1D::hphNT leu2-3,112::GAL1-RNH1 (2-348) (LEU2+)
This study N/A
S. cerevisiae (from W303) CS3664MATa sen1-3-TAP (kanMX)
mrc1D::hphNT leu2-3,112::GAL1-RNH1 (2-348) (LEU2)
This study N/A
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S. cerevisiae (fromW303) CS3702MATa TAP-SLD5 (kanMX) SEN1-9MYC
(hphNT) pep4D::URA3 ADE2 ctf4D::kanMX mrc1-3IAA (HISMX) ADH1-
OsTIR1 (klTRP1,URA3)
This study N/A
S. cerevisiae (from W303) CS3731MATa SEN1-TAP (kanMX) leu2-
3,112::GAL1-RNH1 (2-348) (LEU2)
This study N/A
S. cerevisiae (from W303) CS3733MATa sen1-3-TAP (kanMX) leu2-
3,112::GAL1-RNH1 (2-348) (LEU2)
This study N/A
S. cerevisiae (from W303) CS3796MATa SEN1-TAP (kanMX)
mad2D::kanMX
This study N/A
S. cerevisiae (from W303) CS3797MATa sen1-3-TAP (kanMX)
mad2D::kanMX
This study N/A
S. cerevisiae (from W303) CS3903MATa leu2-3,112::GAL1-RNH1
(2-348) (LEU2) SEN1-TAP (kanMX) hpr1D::kanMX
This study N/A
S. cerevisiae (from W303) CS3905MATa leu2-3,112::GAL1-RNH1
(2-348) (LEU2) sen1-3-TAP (kanMX) hpr1D::kanMX
This study N/A
S. cerevisiae (from W303) CS4296MATa SEN1-TAP (kanMX)
chl1D::kanMX
This study N/A
S. cerevisiae (from W303) CS4298MATa sen1-3-TAP (kanMX)
chl1D::kanMX
This study N/A
S. cerevisiae (from W303) CS4312MATa NRD1-TAP (kanMX)
SEN1-9MYC (hphNT) pep4D::URA3-CP ADE2
This study N/A
S. cerevisiae (from W303) CS4314MATa SEN1-TAP (kanMX)
pep4D::ADE2 rpb1-1 (ts)
This study N/A
S. cerevisiae (from W303) DLY2057MATa sen1-1 (ts) Lab strain N/A
S. cerevisiae (from W303) DLY2281MATa upf1D::TAP::klTRP1 Lab strain N/A
S. cerevisiae (fromW303) DLY3111MATa sen1-1 (ts) upf1D::TAP::klTRP1 This study N/A
S. cerevisiae (from W303) DLY3190MATa SEN1-TAP (kanMX)
upf1D::TAP::klTRP1
This study N/A
S. cerevisiae (from W303) DLY3191MATa sen1-3-TAP (kanMX)
upf1D::TAP::klTRP1
This study N/A
Oligonucleotides
DL377ATGTTCCCAGGTATTGCCGA This study N/A
DL378ACACTTGTGGTGAACGATAG This study N/A
DL474GCAAAGATCTGTATGAAAGG This study N/A
DL475CGCAGAGTTCTTACCAAACG This study N/A
DL481TAAATGGCCAACCGCTGTTG This study N/A
DL482CCAGCGTACTGCACGCCAGG This study N/A
DL1119AAGTGACGAAGTTCATGCTA This study N/A
DL1120TCCGTGTCTCTTGTCCTGCA This study N/A
Recombinant DNA
pYM-N24 Janke et al., 2004 Euroscarf
pCS14pRS305-GAL1-TAP-Ø This study N/A
pCS25pRS305-GAL1-3HA-Ø This study N/A
pCS26pRS305-GAL1-3HA-SEN1 (2-931) This study N/A
pCS30pRS305-GAL1-TAP-SEN1 (2-931) This study N/A
pCS31pRS305-GAL1-TAP-SEN1 (2-1103) This study N/A
pCS32pRS305-GAL1-TAP-SEN1 (931-2231) This study N/A
pCS33pRS305-GAL1-TAP-SEN1 (1095-2231) This study N/A
pCS39pRS305-GAL1-TAP-SEN1 (2-2231) This study N/A
pCS40pRS305-GAL1-TAP-SEN1 (2-1901) This study N/A
pCS42pRS305-GAL1-3HA-SEN1 (2-622) This study N/A
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pCS43pRS305-GAL1-3HA-SEN1 (410-931) This study N/A
pCS59pRS305-GAL1-3HA-SEN1 (501-931) This study N/A
pCS61pRS305-GAL1-3HA-SEN1 (622-931) This study N/A
pCS118pRS305-ACT1-3HA-SEN1 (931-2231) This study N/A
pCS120pRS305-ACT1-3HA-SEN1 (2-2231) This study N/A
pCS123pRS305-ACT1-3HA-SEN1 (2-2231) W773A E774A W777A This study N/A
pCS124pRS305-ACT1-3HA-SEN1 (2-2231) L656A S657A K658A
I659A L660A
This study N/A
pCS125pRS305-ACT1-3HA-SEN1 (2-2231) D850A E851G V852A
L853G L854A
This study N/A
pCS127pRS305-ACT1-3HA-SEN1 (2-2231) D876G D877G V880G This study N/A
pCS128pRS305-ACT1-3HA-SEN1 (2-2231) V746G D747G P748G I749G This study N/A
pCS129pRS305-ACT1-3HA-SEN1 (2-2231) T782G I783G Y784G This study N/A
pCS188pRS305-GAL1-RNH1 (2-348) This study N/A
pCS196pRS424-GPD-hsRNASEH1 (2-286) From Palancade’s lab N/A
pCS197pRS315-ADE2 This study N/A
pCS198pRS315-ADE2-ARS306 This study N/A
pLpRS316-leu2D30-39bp-leu2D50 From Aguilera’s lab N/A
pLYDNSpRS316-leu2D30-3900bp-leu2D50 From Aguilera’s lab N/A
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De Piccoli (g.de-piccoli@warwick.ac.uk). All unique/stable reagents generated in this study are available from the Lead Contact with
a completed Materials Transfer Agreement.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Saccharomyces cerevisiae is the experimental model used in this study. All strains are isogenic to W303, and are listed in the Key
Resources Table.
METHOD DETAILS
Yeast Strains and Growth Conditions
All yeasts were grown in YP medium supplemented with either glucose (YPD) or galactose (YPGAL) or raffinose (YPRAF) to a final
concentration of 2% (w/v). For solid media, the same formulation was used, but with a final concentration of 1% (w/v) agar. Yeasts
were grown at 24, 28, 30 and 37C, depending on their viability at the different temperatures and as required by the experimental
design. For all experiments, the control and test strains were subjected to the same conditions, including temperature.
For cell spotting experiments, cells were grown on non-selective media until colonies were judged to be sufficiently big. Five
discrete colonies from individual strains were added to sterile deionised water to create a cell suspension. From this suspension,
serial dilutions (0.5 x106, 0.5 x105, 0.5 x104 and 0.5 x103 cells/ml) were generated. 10 mL of each suspension was pipetted onto
the appropriate media and grown for up to 5 days at the required temperatures.
To assess the genetic interaction between two or three genes, parents carrying the appropriate alleles were first crossed. Analysis
of the meiotic progeny was conducted by inducing sporulation of the diploid strains in sporulation medium for 3-5 days at 24C. AsciCell Reports 30, 2094–2105.e1–e9, February 18, 2020 e6
were treated with a 1:10 dilution of b-glucoronidase from Helix pomatia (Sigma) for 30 minutes, followed by tetrad dissection onto a
YPD plate using a Singer MSM400 micromanipulator. Plates were incubated for 3-4 days at the appropriate temperature.
For the plasmid recombination assay, eight independent clones carrying the appropriate plasmid (pL or pLYDNS) were each plated
in medium lacking leucine (to select for recombination) or lacking uracil (marker for the presence of the plasmid) at 24C. The exper-
iment was repeated in triplicate. For plasmid loss assays, cells were transformed with the required plasmid (pCS197 or pCS198) and
plated onminimummedium lacking leucine and incubated at 24C. Colonies were left to grow until single isolated colonies were suf-
ficiently big. Five to seven colonies for each strain were then picked, resuspended in sterile water and counted. Around 200-150 cells
were then plated onto YPD and incubated at 24C until red/white coloring was clearly visible. Cells were then incubated at 4C for
three days.We considered white and sectored colonies aswhite while only fully red colonies were scored as red. The experiment was
repeated twice. The plasmid loss assay with or withoutGAL-RNH1was conducted in a similar manner, except that cells were grown
and transformed in medium containing galactose and selected in medium lacking adenine (LEU2 is the reporter gene for the GAL1-
RNH1 construct). Colonies were grown for longer periods of time before colonies were sufficient size big and were plated onto non-
selective medium containing galactose.
Cell cycle experiments
Cells were diluted from an inoculum to a density of 0.353 107 cells/ml in a suitable volume and left to grow to a final density of 0.73
107 cells/ml. The cells were then synchronized in G1 by adding a-factor to a final concentration of 7.5 mg/ml. After the first 90 min,
a-factor was added every 30 min to a 3.25 mg/ml final concentration to maintain the cells in G1. When the cultures were shifted to
37C, cells were spun down and resuspended in pre-warmed medium containing 7.5 mg/ml a-factor. Cells were released from the
arrest by washing the cells twice with medium without a-factor. In all experiments in which cells were collected for IPs, cells were
grown at 24C and released into S phase for 30 min, unless stated otherwise in the figure legend. For expressing constructs under
the GAL1 promoter, strains were grown in YPRAF, arrested in G1 using a-factor, upon which YPGAL was substituted for YPRAF.
Alternatively, YPGAL was used throughout the experiment (appropriate for constructs that were labile).
Harvesting cells for IP
Harvested cells were immediately cooled to 4Cbywashingwith an ice-cold solution of HEPES-KOH (pH 7.9), followed by awash in a
solution of 100 mM HEPES-KOH (pH 7.9), 50 mM potassium acetate, 10 mMmagnesium acetate and 2 mM EDTA-KOH, still at 4C.
After the wash, the solution was discarded and the cells were re-suspended in a fresh quantity of the same solution supplemented
with protease and phosphatase inhibitors, so that the ratio of wet mass of the cells to the final mass of the suspension was either 1:4
(for 250 mL cultures) or 4:5 (for 1 l cultures). The re-suspended cells were immediately flash-frozen by pipetting into a flask holding
liquid nitrogen. The frozen cells were kept at80C until use for IP. Before freezing, some cells were fixed in 70% (v/v) ethanol to test
that cells did not progress through the cell cycle during sample preparation.
For cells with inducible constructs, cultures were grown as described above in YPRAF. After the cells were arrested in G1, the cul-
ture was substituted with YPGAL (supplemented with a-factor) to induce transcription from the GAL1 promoter. Harvesting of G1
cultures can be performed prior to or after induction according to the experimental setup. After 35 min or 1 h of induction, the cells
were released in S phase as described above and harvested either 30 min (24C) or 20 min (30C or 37C) post-release. For temper-
ature-sensitive strains or strains tagged with a temperature-degron (e.g psf1-1, td-sld3-7 and rnh1D rnh201D ACT1-sen1-3), the
strains were grown and synchronized in G1 at 24C as described above. Once synchronized and, (optionally) constructs transcrip-
tionally induced, the cells were shifted to 37C for 1 h. a-factor was added every 20 min to maintain the cells in G1 to a final concen-
tration of 7.5 mg/ml for 1 h. Synchronicity was monitored visually using a microscope and by harvesting a 1 mL sample of the culture
by fixing in 70% (v/v) ethanol for flow-cytometric analysis. The cells were then washed and released in S phase. The cells were har-
vested 20min after release, including for the psf1-1 strains that do not actually undergo DNA replication at 37C as the GINS complex
is destabilized. For crosslinking IPs, cells cultures were incubated with formaldehyde for 25 min and treated as in De Piccoli et al.
(2012).
Western Blots
Protein samples (TCA-precipitated and non-treated cell extracts, as well as IPs) were run on 5, 6, 7, 8 or 10% polyacrylamide gels.
The protein bands were then transferred onto nitrocellulose or PVDF membranes. The proteins bands were then probed with the
appropriate primary antibodies for 1 h in a solution of 5% (w/v) skimmedmilk in TBST, washed thrice for 5 min in fresh TBST, probed
with the appropriate HRP-bound secondary antibody (if any, refer to Key Resources Table) and washed thrice again for 5 min in fresh
TBST. The membrane was then treated with the western blotting reagents and the resulting chemiluminescent signal was captured
using either films or a digital camera (G:BOX, Chemi XRG, Syngene).
IP
IPs were conducted as previously described (De Piccoli et al., 2012). In brief, cells previously harvested were lysed using a mecha-
nised pestle and mortar at 80C (Spex Sample Prep, 6870). 1 g of lysate is considered equivalent to 1 ml. To 1 volume of thawed
lysate, ¼ volume of a solution of 50% (v/v) glycerol, 100 mM HEPES-KOH (pH 7.9), 50 mM potassium acetate, 50 mM magnesium
acetate, 0.5% (v/v) Igepal CA-630, 2mM EDTA supplemented with protease and phosphatase inhibitors was added. Piercee7 Cell Reports 30, 2094–2105.e1–e9, February 18, 2020
Universal Nuclease was added to a final concentration of 0.4 U/ml and samples were left on a rotating platform at 4C for 30min. After
incubation, the sample was clarified by stepwise centrifugation at 18,700g and then at 126,600g. The supernatant was isolated, 50 mL
of which was added to 100 mL of 1.5 x Laemmli buffer (cell extract). The remaining cell extract was incubated with 100 mL of TAP-
beads for 2 h (M-270 Dynabeads Epoxy beads bound to an anti-sheep IgG). Beads were washed with solutions of 100 mM
HEPES-KOH (pH 7.9), 50 mM potassium acetate, 50 mM magnesium acetate, 2 mM EDTA, 0.1% (v/v) Igepal CA-630 thrice. After
washing, 100 mL of 1 x Laemmli buffer was added to the 100 mL of TAP-beads and boiled for 4 min. Crosslinking IPs were conducted
as in De Piccoli et al. (2012).
When scaling up was necessary (using 1 l of cells instead of 250ml), a few changes were implemented to the protocol. Notably, the
concentration of the Pierce Universal Nuclease was increased four-fold to a final concentration of 1.6 U/ml and incubation with the
nuclease was increased from 30 to 40 min.
MS Analysis of IPs
The samples were processed as above. Following the washes, TAP-Sen1 (2-931) protein was released by using the AcTEV prote-
ase at 24C for 2 h. Thereafter, the resultant CBP-Sen1 (2-931) (CBP: calmodulin-binding protein) and its specific interactors were
incubated with pre-washed calmodulin beads at 4C for 2 h. After washing, 30 mL of 1 X Laemmli was added to the calmodulin beads
and boiled for 4 min. The samples from the four biological replicates were pooled together, flash-frozen on dry ice and stored at
80C. The samples were then run on commercially sourced 4%–12% acrylamide gel for a short distance (1 cm). The gel was
then cut in thin slices and processed and analyzed by MS Bioworks, USA.
Counting of Rad52-foci to assess DNA damage
Cells carrying the RAD52-GFP allele were first grown in liquid medium and synchronized in G1. Cells were released and harvested at
different times after release, corresponding to different phases of the cell cycle. Paraformaldehydewas added to the cell suspensions
to a final concentration of 3% (w/v) and the samples were incubated at room temperature for 10min. The cells were then washedwith
PBS at room temperature. Finally, the samples were re-suspended in fresh PBS and kept at 4C overnight.
Less than 24 h after fixation (to minimize signal lost due to alteration of the GFP protein), the samples were re-suspended in 500 mL
of fresh PBS to which the DNA stain DAPI was added to a final concentration of 1 mg/ml. The samples were incubated at room tem-
perature for 10 min to allow for staining of the DNA. The cells were then washed with PBS to improve the signal-to-noise ratio of the
DAPI staining. The cells were then brought to a suitable dilution prior to pipetting on a glass slide onto which a coverslip is applied.
Images of cells were acquired (brightfield, 510 nm emission (GFP), 460 nm (DAPI)) using a Personal DeltaVision (Applied Preci-
sion). The images were analyzed using ImageJ and the number of Rad52-foci were counted. An average of three experiments is
shown in the figures.
Chromosome spreads and microscopy
Chromosome spreads were performed as previously described (Wahba et al., 2011; Grubb et al., 2015). Exponentially growing asyn-
chronous cultures were grown in YPD at 28C. 2x108 cells were harvested and spheroplasted (0.1M potassium phosphate (pH 7.4),
1.2 M sorbitol, 0.5 mM MgCl2, 40 mM DTT, 20 U zymolyase at 30C for 1 h or until > 90% of cells lysed following addition of 2%
sarcosyl. Cells were then washed and resuspended in ice cold 1 M sorbitol (pH 6.4), 0.1 M MES, 0.5 mM MgCl2, 1 mM EDTA to
stop spheroplasting reaction. 20 mL of cell suspension was placed onto a slide, followed by 40 mL of fixative (4% paraformaldehyde
(w/v), 3.4% sucrose (w/v)), then lysed using 80 mL of 1% lipsol (v/v) for 2 min, followed by addition of 80 mL of fixative and spread
across the surface of the slide to dry overnight. Slides pre-treated with RNase H were incubated with 4U of RNase H diluted in
400 mL of 5mg/ml BSA for 1 h at 37C prior to immunostaining. Slides were immunostained for DNA:RNA hybrids usingmousemono-
clonal antibody S.96 (Kerafast) diluted 1:2000 (0.25 mg/ml) in blocking buffer (5% BSA, 0.2% milk, 1XPBS) for 1 h. The secondary
antibody, Cy3-conjucated goat anti-mouse (Jackson laboratories) was diluted 1:2000 in blocking buffer and incubated in the dark
for 1 h. Indirect immunofluorescence was observed using a Deltavision 1 microscope with a 1003 /NA 1.4 objective. Image analysis
was performed using ImageJ and Adobe Photoshop. An average of three experiments is shown in the figures.
Quantification of R-loops
Cells growing in liquid culture was harvested and re-suspended in lysis solution (100 mMNaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA,
3% (w/v) SDS). To a volume of cell suspension, an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) (Acros Organics) and
another volume of nuclease-free deionised water were added. The cells were then lysed mechanically using glass beads and DNA
was isolated by incubating the soluble cell extract to ethanol to a final concentration of 70% (v/v). The DNA was washed with fresh
ethanol and re-suspended in nuclease-free TE supplemented with 50 mg/ml RNase A and incubated at 37C for 1 h only.
The concentration of genomicmaterial was estimated bymeasuring absorbance at 260 nm. For each sample, 1 mg/ml, 0.5 mg/ml and
0.25 mg/ml dilutions of DNA was prepared, using nuclease-free water. 2 mL of each dilution was treated with either 1U of RNaseH
(Invitrogen, #18021071) or 1 U of RNaseH and 1 U of RNase III (Invitrogen, #AM2290) with similar results at 37C for 1h. As a control,
untreated samples were also incubated at 37C for 1 h. The remaining DNAwas then added to 200 mL of 2 X SSC hybridization buffer
(0.3M NaCl, 30mM trisodium Citrate, pH 7.0) and transferred to a pre-equilibrated hybond-N+ nylon membrane (GE healthcare,
#RPN203B) under vacuum. The DNA was cross-linked to the membrane using UV prior to blocking in either 5% (w/v) milk (anti-RCell Reports 30, 2094–2105.e1–e9, February 18, 2020 e8
loops) or 5% (w/v) BSA (anti ds-DNA) at 24C for 1 h. The membranes were then incubated overnight in 5% milk supplemented the
primary antibody at 4Covernight. After thricewashing in TBST for 30min, themembranewas incubatedwith anti-mouse IgG-HRP at
24C for 1 h. The membranes were treated with ECL, and chemiluminescent signal was visualized using a camera (G:BOX, Chemi
XRG, Syngene).
Reverse transcription followed by quantitative PCR
Cells were grown to exponential phase and incubated at permissive (24C) or non-permissive temperatures (37C) for 3 h to induce
the sen1-1 phenotype before collection. Analysis was performed in parallel in an upf1D background for detecting elongated RNA
species derived from termination failure that might be degraded in the cytoplasm. The ratio of the read-through fraction over the total
amount of SNR13 RNA is shown as a proxy of transcription termination levels. The mean of three experiments is shown. Error bars
represent the standard deviation. Cells were grown in logarithmic phase, and 6 OD600 worth of cells were pelleted. Total RNAs were
extracted by resuspending cell pellets in 1 volume of acidic phenol (pH 4.3) supplemented with 1 volume of AES Buffer (50 mM So-
dium Acetate pH 5.5, 10mMEDTA, 1%SDS). Mixtures were incubated at 70Cwith agitation (1,400 rpm) for 30min in a thermomixer
(Eppendorf), before being centrifuged at 20,000 g at 4C for 10 min. Aqueous phases were recovered and subjected to one extra
round of hot acidic phenol extraction, followed by one round of chloroform extraction. Total RNAs were finally precipitated with ab-
solute ethanol and sodium acetate pH 5.5, washed once with 70%Ethanol, dried on a SpeedVac (Thermo) and resuspended in 30 mL
of RNase-free H2O. 60-120 mg of total RNAs were recovered routinely.
Reverse transcription was performed using random hexamer-primers annealing at multiple loci in the S. cerevisiae genome and
with oligos dT. 4 mg of total RNAs were mixed to 200 ng of random hexamers and 0.5 mM of oligos dT in a 20 mL reaction containing
50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2 and 5 mM DTT. Samples were first incubated for 15 min at 70C to allow RNA
denaturation. Then temperature was slowly decreased to 37C to allow annealing of primers. Lastly, synthesis of cDNAs was per-
formed by adding 200 units of MLV-reverse transcriptase for 45 min at 37C.
To assess the amount of cDNAs reverse transcribed, quantitative PCR (qPCR) was carried out using two different primer pairs for
each target (SNR13, NEL250c, ACT1). These allowed the amplification of a product covering either 300 bp of the 30 end of ACT1
(DL377/DL378 primer pair) or 70 bp in the read-through region of SNR13 (DL1119/DL1120 primer pair) or 140 bp in the body of
NEL025c (DL474/DL475 primer pair) or 70 bp in the read-though region of NEL025c (DL481/DL482 primer pair). qPCR was per-
formed in a 10 mL reaction by mixing 2 mL of the reverse transcribed cDNAs to 5 mL of LightCycler 480 SYBR Green I Master
and 2.5 pmol of both the forward and the reverse primer.
Cross-linking and analysis of cDNA (CRAC)
The CRAC protocol used in this study is derived from Granneman et al. (2009) with a few modifications as described in Candelli et al.
(2018). Raw data processing has been performed as described in Candelli et al. (2018). Metagene analysis has been performed as
follows: for the CUTs presented in Table S1, we retrieved the polymerase reads count at every position around the features (30 or 50
end) and plotted the mean over all the values for these positions in the final aggregate plot. Analysis has been performed in the R
Studio environment.
QUANTIFICATION AND STATISTICAL ANALYSIS
Where applicable, data was presented as the average ± standard deviation. t tests were used to compare population means. Sta-
tistically significant differences were indicated as such by indicating the value range of the p values.
DATA AND CODE AVAILABILITY
The published article includes all datasets generated or analyzed during this study. The raw data of the metagene analysis of the
CUTs shown in Figure 4B are included in Table S1. This study did not generate any unique code.e9 Cell Reports 30, 2094–2105.e1–e9, February 18, 2020
